Supernus Pharmaceuticals Selects DSG, Inc. for EDC and IWRS in Phase 3 Clinical Studies

Read more

Eisai Signs Three-Year Contract Extension For CSC’s TRS as-a-Service

Read more

Marina Biotech Announces a License Agreement to Deliver a Genome Editing Technology

Read more

New England Biolabs Selects Symmetry for Comprehensive SAP HANA Cloud Migration

Read more

Medidata’s Cloud Technology Powers U.S. Government Research on Drug Development Costs

Read more

Grünenthal selects Patheon to develop drugs using INTAC abuse deterrent formulations technology

Read more

Oracle Health Sciences to Provide Clinical E-Monitoring Solution to Bayer HealthCare

Read more

DNAtrix’s Oncolytic Immunotherapy, DNX-2401, Awarded EU Orphan Medicine Designation for Treating Malignant Brain Tumors

Read more

Panacea Pharmaceuticals selects Goodwin to develop anti-cancer monoclonal antibody

Read more

Genomics England selects QIAGEN hereditary and rare disease solution

Read more